In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer. Lu L, Ma W, Johnson CH, Khan SA, et al. Vaccine 2023 Feb 20:S0264-410X(23)00183-4. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Lu L, Ma W, Johnson CH, Khan SA, et al. In silico designed mRNA vaccines targeting CA-125 neoantigen in breast and ovarian cancer. Vaccine 2023 Feb 20:S0264-410X(23)00183-4. doi: 10.1016/j.vaccine.2023.
PMID: 36813666